Genetic Analysis AS
Edit

Genetic Analysis AS

https://www.genetic-analysis.com/
Last activity: 05.05.2025
Active
Categories: ActiveAnalyticsBioTechDataDiagnosticsHealthTechPlatformProductResearchTechnology
Genetic Analysis AS (GA) is positioned to become a world leader within the field of molecular in-vitro diagnostics of diseases related to gut imbalances.
Based on the patented DNA-based GA-map® platform technology, profiles of patient’s gut microbiota is quickly generated and can be related to various health conditions.
Our first product, the GA-map® Dysbiosis Test helps Gastroenterologists to measure and monitor gut microbiota status in patients with Irritable Bowel Syndrome (IBS).
This is the first dysbiosis test which is commercially available, standardised, CE-marked and clinically validated (50 clinical trials + 30 publications).
Further clinical applications for the tests are in areas such as diagnosis, disease severity course, treatment prediction and monitoring within both IBS (irritable bowel syndrome) and IBD (inflammatory bowel disease) where the need of clinical data and validation is required.
GA is thus very active in these fields.
Other areas of interest are metabolic disease including diabetes type 2.
Followers
548
Followers
1.85K
Mentions
113
Location: Norway, Oslo
Employees: 11-50
Founded date: 2008
Twitter
Facebook
LinkedIn
Email

Mentions in press and media 113

DateTitleDescription
06.05.2025Genetic Analysis AS: Navigating Change and Growth in the Microbiome SectorIn the heart of Oslo, Genetic Analysis AS is poised for transformation. The company, a pioneer in microbiome diagnostics, is set to hold its annual general meeting on May 19, 2025. This gathering is not just a formality; it’s a crossroads f...
06.05.2025Genetic Analysis Secures NOK 12.8 Million Through Directed Share IssueIn a strategic move to bolster its financial footing, Genetic Analysis AS (GA) has announced a directed share issue, raising NOK 12.8 million. This decision, driven by commitments from existing major shareholders, marks a significant step f...
05.05.2025Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 millionCorrection: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million Mon, May 05, 2025 09:45 CET Report this content Correction due to an incorrect date in the preamble regarding the calculation of the subscription...
05.05.2025Genetic Analysis announces placement of a directed share issue of NOK 12.8 millionGenetic Analysis announces placement of a directed share issue of NOK 12.8 million Mon, May 05, 2025 08:00 CET Report this content NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDO...
05.05.2025Notice of annual general meetingNotice of annual general meeting Mon, May 05, 2025 08:05 CET Report this content OSLO, NORWAY – 5 May 2025: Notice is hereby served that the annual general meeting in Genetic Analysis AS (the "Company") will be held on Monday 19 M...
05.05.2025Genetic Analysis announces proposed changes to the BoardGenetic Analysis announces proposed changes to the Board Mon, May 05, 2025 08:02 CET Report this content OSLO, NORWAY – 5 May 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) today announces that its Election Committee has ...
02.05.2025Genetic Analysis AS publishes Annual Report 2024Genetic Analysis AS publishes Annual Report 2024 Fri, May 02, 2025 09:00 CET Report this content OSLO, NORWAY – 2 May 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the Annual Report for the financial yea...
22.04.2025Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health marketGenetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market Tue, Apr 22, 2025 08:00 CET Report this content OSLO, NORWAY/SHANGHAI, CHINA – 22. April 2...
26.02.2025Genetic Analysis AS publishes year-end report 2024Genetic Analysis AS publishes year-end report 2024 Wed, Feb 26, 2025 08:00 CET Report this content OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the per...
20.12.2024GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TESTGENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST Fri, Dec 20, 2024 17:12 CET Report this content Collaboration announced to develop and launch a new rapid microbiome-bas...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In